All Work

Jon C. Ogg

Pending Home Sales Still Look Rocky

Flickr, Images of MoneyWhat happened to all the reports about the bottom in the housing market?  The number of pending home buyers who have signed contracts to buy a house fell in February. Data…

Jon C. Ogg · 15 years ago

More Caution Remains in LED Sector (AIXG, VECO, RBCN, CREE)

Canaccord Genuity is bringing up more caution in the LED sector this Monday.  The analyst team is attributing recent strength due to restocking and double ordering.  Canaccord’s rating call is cutting Aixtron SE (NASDAQ:…

Jon C. Ogg · 15 years ago

Will Investors Turn Away From CDs Forever?

The environment of ‘exceptionally low interest rates’ may help borrowers, but it has the unintended consequences of bringing real returns to zero or even negative if you consider the impact of inflation against nominal…

Jon C. Ogg · 15 years ago

Bernanke Talks Up The Jobs Market

Federal Reserve Chairman Ben Bernanke is giving a speech at the National Association for Business Economics Annual Conference in Washington, D.C. titled simply “Recent Developments in the Labor Market.”  Mr. Bernanke is talking about…

Jon C. Ogg · 15 years ago

Baker Hughes Shows Falling Rig Counts (BHI)

Baker Hughes Inc. (NYSE: BHI) is out with its weekly data on United States and Canadian oil and gas rigs for the last week.  The trend is down for North America as the U.S.…

Jon C. Ogg · 15 years ago

Peabody Warning Still Somewhat In-Line (BTU)

Peabody Energy Corporation (NYSE: BTU) is issuing an earnings warning, but not from the normal logic behind most warnings.  The warning is said to be due to Australia weather-related events.  The first quarter financial…

Jon C. Ogg · 15 years ago

The Management Gap at First Solar (FSLR)

First Solar, Inc. (NASDAQ: FSLR) has been one of the worst performing stocks out there over the last year.  Michael Ahern is searching for a new CEO after a departure or termination of Rob…

Jon C. Ogg · 15 years ago

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front.  The companies have announced that the European Commission has now approved its Type-2 Diabetes…

Jon C. Ogg · 15 years ago